Bionabu
Bionabu is a London-based clinical trial integrity software company serving pharmaceutical and biotech sponsors. Its platform combines pediatric patient preparation (PrepStoriesAI®), content governance (Vera Content), and protocol deviation management (Vera Deviate).
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Bionabu firmographics
Firmographics- Name
- Bionabu
- Website
- https://bionabu.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bionabu is a London-based clinical trial integrity software company serving pharmaceutical and biotech sponsors. Its platform combines pediatric patient preparation (PrepStoriesAI®), content governance (Vera Content), and protocol deviation management (Vera Deviate).
- Ownership category
- akta.pro rank
Bionabu industry classification
Industry- Product category
- Clinical Trial Management Software
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Regulatory Submissions & Clinical Content Management (eCTD/Publishing) (HLACAOAN), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)
Keywords
Where Bionabu is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Bionabu business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels2 records
Bionabu product offering
Product offeringCore offering
Bionabu operates a Clinical Trial Integrity Platform that integrates pediatric patient preparation content, content governance, and protocol deviation management into a single system for clinical trial sponsors. The platform includes PrepStoriesAI® with The Child Metaphor Bank™, Vera Content for communication governance, Vera Deviate for deviation control, and a Readiness Framework for clinical operations assessment.
Product overview
Bionabu offers a unified Clinical Trial Integrity Platform designed to ensure compliance and quality from patient understanding through regulatory inspection. The platform consists of multiple integrated modules: PrepStoriesAI® (for pediatric patient preparation with The Child Metaphor Bank™), Vera Content (for content governance), and Vera Deviate (for protocol deviation control), all working together to prepare patients, govern content, and control deviations throughout the clinical trial lifecycle.
Differentiator
Problem solved
Functional benefit
Products and services
- PrepStoriesAI®
Companies that use Bionabu
Customer profileSegments1 record
Ideal customer profiles1 record
Bionabu technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Bionabu partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
Bionabu competitors and assessment
Company assessmentDirect peers
- ArisGlobal: Life sciences R&D platform spanning clinical trial management, regulatory, safety, and content workflows. Competes with Bionabu on the regulatory-grade content and trial integrity narrative.
- Clario: Clinical trial technology vendor combining eCOA, imaging, and endpoint adjudication. Overlaps with Bionabu on patient-facing clinical software purchased by pharma/biotech sponsors.
- Signant Health: Provider of eCOA, ePRO, and patient engagement solutions for clinical trials. Directly comparable in patient-facing clinical software sold to pharma sponsors, including pediatric-population support.
- Veeva Systems: Dominant cloud-platform provider for pharma clinical, regulatory, and quality operations (Veeva Vault, CDB, CTMS). Competes directly with Bionabu's clinical content governance and trial integrity positioning across pharma sponsors.
- Castor: Cloud EDC and decentralized trial platform used by sponsors and CROs. Comparable to Bionabu in providing trial-configurable clinical software infrastructure to pharma and academic sponsors.
- Medidata (Dassault Systèmes): Provider of the Rave EDC/CTMS/eCOA platform used in a large share of clinical trials. Overlaps with Bionabu on eCOA-style patient-facing clinical software for sponsors and CROs globally.
- Clinical Ink: eCOA, ePRO, and patient engagement platform for clinical trials. Direct overlap with Bionabu's patient-facing clinical software modules sold to pharma sponsors and CROs.
- THREAD: Decentralized clinical trial platform offering eCOA, ePRO, and patient engagement tools. Comparable to Bionabu in delivering patient-facing trial infrastructure to sponsors across geographies.
- Oracle Clinical One: Oracle's unified clinical trial platform covering EDC, RTSM, CTMS, and eCOA. Competes with Bionabu's integrated approach to trial integrity across the same enterprise pharma buyer base.
Emerging players
- BBK Worldwide: Patient recruitment and engagement services for clinical trials, including pediatric populations. Adjacent to Bionabu's patient preparation wedge — competes for sponsor patient-engagement budget with a services-led model.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights5 records
Customer concentration
Bionabu social profiles
Digital presenceBionabu financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bionabu leadership team
Management profileNumber of profiles
Bionabu funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bionabu M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bionabu
What does Bionabu do?
Bionabu operates a Clinical Trial Integrity Platform that integrates pediatric patient preparation content, content governance, and protocol deviation management into a single system for clinical trial sponsors. The platform includes PrepStoriesAI® with The Child Metaphor Bank™, Vera Content for communication governance, Vera Deviate for deviation control, and a Readiness Framework for clinical operations assessment.
Is Bionabu a public or private company?
Bionabu is a private company. It is classified as unknown and is currently operating.
When was Bionabu founded?
Bionabu was founded in 2021. It employs 11 to 50 people.
Where is Bionabu based?
Bionabu is headquartered in London, United Kingdom, in the Europe region.
Who are Bionabu's main competitors?
Direct peers on record are ArisGlobal, Clario, Signant Health, Veeva Systems, Castor, Medidata (Dassault Systèmes), Clinical Ink, THREAD and Oracle Clinical One. BBK Worldwide is listed as an emerging player.
Does Bionabu have an API?
No public API is recorded for Bionabu.
What industry is Bionabu in?
Bionabu's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACAOAN, Regulatory Submissions & Clinical Content Management (eCTD/Publishing). Its SIC code is 7372.